Cargando…
Characterisation of an ABC transporter of a resistant Candida glabrata clinical isolate
BACKGROUND: Candida glabrata ranks second in epidemiological surveillance studies, and is considered one of the main human yeast pathogens. Treatment of Candida infections represents a contemporary public health problem due to the limited availability of an antifungal arsenal, toxicity effects and i...
Autores principales: | Rocha, Debora Afonso Silva, de Sa, Leandro Figueira Reis, Pinto, Ana Carolina Cartagenes, Junqueira, Maria de Lourdes, da Silva, Emiliana Mandarano, Borges, Ronaldo Mohana, Ferreira-Pereira, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Oswaldo Cruz, Ministério da Saúde
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851027/ https://www.ncbi.nlm.nih.gov/pubmed/29412345 http://dx.doi.org/10.1590/0074-02760170484 |
Ejemplares similares
-
The Anti-Virulence Effect of Vismia guianensis against Candida albicans and Candida glabrata
por: Motta, Elizangela Pestana, et al.
Publicado: (2022) -
ABC transportome inventory of human pathogenic yeast Candida glabrata: Phylogenetic and expression analysis
por: Kumari, Sonam, et al.
Publicado: (2018) -
Adhesins in Candida glabrata
por: Timmermans, Bea, et al.
Publicado: (2018) -
Candida glabrata candidemia
por: Chakrabarti, Arunaloke
Publicado: (2015) -
Candida Glabrata Esophagitis: new case reports and management
por: Macêdo, Danielle Patrícia Cerqueira, et al.
Publicado: (2008)